Healthcare Technology Industry News
A collection of Healthcare Technology latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
GE HealthCare Technologies Inc. stock falls Thursday, underperforms market
Shares of GE HealthCare Technologies Inc. GEHC slid 2.12% to $81.89 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.02% to 7,175.83 and Dow Jones Industrial Average DJIA…
Nadda pushes technology for healthcare, warns against misuse for sex selection
2 min read New Delhi Make us preferred source on Google AI Narration AI Narration This audio is AI generated. Your feedback has been reported succesfully. Union Health Minister J P Nadda on Thursday said technology must be harnessed to advance…
Israel's emerging Traumatech industry offers hope for mental health treatment
After three years of covering Israel at war, journalist and author Maayan Hoffman found herself asking a question: How are we ever going to heal? She had walked through devastated kibbutzim, interviewed hostages and their families, spoken with…
Allspring Mid Cap Growth Fund Q3 2026 Commentary
The fund outperformed the Russell Midcap Growth Index during the third quarter. Security selection within health care and information technology contributed to performance. An overweight to industrials and selection in financials detracted from…
HKTDC opens BIP Asia Forum and Entrepreneur Day
The 16th Business of IP Asia Forum (BIP Asia Forum), jointly organized by the Hong Kong Trade Development Council (HKTDC) and the government, and the 18th Entrepreneur Day (E-day), organized by the HKTDC, opened Thursday at the Hong Kong Convention…
Goldman Sachs Small Cap Equity ETF Q3 2026 Commentary
During the quarter, the Goldman Sachs Small Cap Equity ETF returned -10.68% (based on NAV, net of fees), underperforming its benchmark the Russell 2000 Index by 345 BPs. The S&P 500 Index increased by 2.30% (total return, in USD) in the third…
Bill Zerella, Known for Taking Startups Public, on Why He Joined Stord as CFO
Good morning, CFOs. There are CFOs who take companies public. And then there are CFOs who do it again and again. Bill Zerella is the latter. That's what interested me about Zerella, who recently joined the supply-chain company Stord as CFO. Stord…
Delhi Lt Governor Calls For Joint NCR Push On Traffic, Housing
Lt Governor Taranjit Sandhu was addressing at 'Delhi Connects 2026', an ASSOCHAM conference, Thursday. For a commuter travelling between Delhi and Gurugram or Noida, a state border may be just another point on the route. For governments, it marks…
Dr. NTRUHS plans AI-based courses in affiliated colleges to strengthen research collaboration
Dr. NTR University of Health Sciences (NTRUHS) is planning to introduce new academic programmes incorporating Artificial Intelligence (AI) and Machine Learning (ML), while strengthening research collaboration among its affiliated medical colleges.
Tech, finance and strategy leadership moves at the C-level to note
Edward Wood has joined the global professional services provider's subsidiary for the U.S. government market as chief technology officer, a role he brings three decades of experience to. Wood most recently worked as global enterprise network lead…
Stryker Sticks to Growth Goals Despite Cyberattack and Slower Orthopedic Market
3 Healthcare Giants Just Raised Dividends—Here's Who Pays the Most Stryker NYSE: SYK expects to maintain its long-term growth and margin goals despite a cyberattack, supply disruptions and a softer U.S. orthopedic market, executives said at…
AES At $15.02: A Late-Stage Merger-Arb With Little Left To Win
I am an independent trader, investor, and market researcher with a background in psychology, quantitative analysis, and systematic strategy development. I began trading financial markets at 18 and have spent the years since developing a deeper…
Natera vs. Tempus AI: Which Blood Test Pioneer Has the Better Stock Buy for 2027?
By Brendan Coffey – Updated Natera dominates the molecular diagnostics market with high revenue growth and positive free cash flow. Tempus AI leverages a massive multimodal data library and artificial intelligence to drive precision…
Grail vs. Tempus AI: Which Healthcare Stock Is a Better Buy for 2027?
By Brendan Coffey – Updated Grail is a leader in early cancer detection through its multi-cancer blood test, Galleri, which is currently undergoing large-scale clinical trials. Tempus AI operates a vast data ecosystem that utilizes…
Trump's HIPAA overhaul makes patients the CEOs of their health - not file clerks
Half the battle for patients is retracing their steps to figure out how they got here. The consequences go beyond frustration. A missing allergy list opens the door to catastrophic medical reactions. A missing CT scan can mean cancer progression…
Receive a Daily briefing on Healthcare Technology Industry News
Get Started